Organism Fungi Aspergillus flavus Aspergillus fumigatus Aspergillus niger Aspergillus terreus Candida glabrata Candida kruseii Candida parapsilosis Candida tropicalis Cryptococcus sp . Pneumocystis carinii & Pneumocystis wakefieldiae Pneumocystis jirovecii Pneumocystis murina Saccharomyces cerevisia

J. Huggett,Michael P Taylor,G. Kocjan,H. Evans,S. Morris-Jones,V. Gant,T. Novak,Anthony Costello,Alimuddin Zumla,Robert F Miller

Abstract:

What problem does this paper attempt to address?

Optimizing pediatric periprocedural pain management part I—Evolving ethics and topical anesthetics

Emily D. Henkel,Courtney N. Haller,Lucia Z. Diaz,Victoria Ricles,Ashley V. Wong Grossman,Michael E. Nemergut,Andrew C. Krakowski

DOI: https://doi.org/10.1111/pde.15635

IF: 1.997

2024-05-15

Pediatric Dermatology

Abstract:Pediatric procedure‐related pain management is often incompletely understood, inadequately addressed, and critical in influencing a child's lifelong relationship with the larger health care community. We highlight the evolution of ethics and expectations around optimizing periprocedural pain management as a fundamental human right. We investigate the state‐of‐the‐art of topical anesthetics, reviewing their mechanisms of action and providing comparisons of their relative safety and efficacy data to help guide clinical selection. In total, this two‐part review offers a combination of conventional approaches and innovative techniques that should be used multimodally—in series and in parallel—to help optimize pain management and provide alternatives to sedation medication and general anesthesia.

dermatology,pediatrics
A Narrative Review of Pain in Pediatric Oncology: The Opioid Option for Procedural and Surgical Pain

Elizabeth A Hall,Chasity M Shelton,Tracy M Hagemann,Hilary M Jasmin,Karissa Grey,Doralina L Anghelescu

DOI: https://doi.org/10.1007/s40272-024-00654-6

2024-09-28

Abstract:This narrative review examines the evolving role of opioids in managing procedural and surgical pain in pediatric oncology patients. The review evaluates studies on opioid use across various oncological surgeries including thoracic, abdominal, orthopedic, and neurosurgical procedures, as well as for common painful procedures such as bone marrow aspirations and lumbar punctures. While opioids remain important for acute procedural and postoperative pain management in pediatric oncology patients, there is an increasing emphasis on multimodal, opioid-sparing approaches. The evidence presented within this review highlights the growing focus on judicious postoperative opioid prescribing to mitigate risks of adverse effects and persistent use or potential misuse. The review synthesizes findings from studies investigating various analgesic regimens, including the use of regional anesthesia techniques like epidural analgesia and peripheral nerve blocks, which have shown promise in reducing opioid requirements. For procedural pain, the review explores the efficacy of combining opioids with sedatives like midazolam or propofol, as well as the potential of ketamine as an opioid-sparing alternative. Key findings indicate that opioid-sparing techniques can effectively reduce overall opioid consumption without compromising pain control or patient satisfaction. Several studies demonstrated that regional anesthesia techniques and non-opioid adjuncts can significantly lower postoperative opioid requirements across various surgical procedures. For procedural pain, ketamine-based regimens often showed comparable or superior pain control to opioid-based approaches, with some studies reporting better patient satisfaction. This review also addresses the importance of tailored postoperative opioid prescribing, with some studies presenting algorithms to predict outpatient opioid needs more accurately. These approaches aim to ensure adequate pain control while minimizing excess opioid dispensing.
Updates from the Other Side of the Drape: Recent Advances in Multimodal Pain Management and Opioid Reduction Among Pediatric Surgical Patients

Andrew D. Franklin,KuoJen Tsao,Rabab Barq,Lorraine I. Kelley-Quon,Giorgio Veneziano,Jennifer H. Aldrink

DOI: https://doi.org/10.1016/j.jpedsurg.2024.03.027

IF: 2.549

2024-03-18

Journal of Pediatric Surgery

Abstract:As the management of acute pain for children undergoing surgical procedures as well as recognition of the short and long term risks of exposure to opioids has evolved, multimodal and multidisciplinary approaches using organized pathways has resulted in improved perioperative outcomes and patient satisfaction. In this 2023 symposium held at the American Academy of Pediatrics on Surgery meeting, a multidisciplinary discussion on current enhanced recovery after surgery pathways, alternate methods of effective pain control and education and advocacy efforts for opioid reduction were discussed, and highlights are included in this article.

pediatrics,surgery
Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults.

Stephanie Weibel,Yvonne Jelting,Nathan L Pace,Antonia Helf,Leopold HJ Eberhart,Klaus Hahnenkamp,Markus W Hollmann,Daniel M Poepping,Alexander Schnabel,Peter Kranke,Leopold Hj Eberhart

DOI: https://doi.org/10.1002/14651858.CD009642.pub3

IF: 8.4

2019-10-03

Cochrane Database of Systematic Reviews

Abstract:The management of postoperative pain and recovery is still unsatisfactory in a number of cases in clinical practice. Opioids used for postoperative analgesia are frequently associated with adverse effects, including nausea and constipation, preventing smooth postoperative recovery. Not all patients are suitable for, and benefit from, epidural analgesia that is used to improve postoperative recovery. The non-opioid, lidocaine, was investigated in several studies for its use in multimodal management strategies to reduce postoperative pain and enhance recovery. This review was published in 2015 and updated in January 2017.

medicine, general & internal
Analgosedation in Pediatric Emergency Care: A Comprehensive Scoping Review

Lorenzo Ciavola,Francesco Sogni,Benedetta Mucci,Eleonora Alfieri,Angela Tinella,Elena Mariotti Zani,Susanna Esposito

DOI: https://doi.org/10.3390/ph17111506

IF: 4.6

2024-11-09

Pharmaceuticals

Abstract:Effective management of pain and anxiety in pediatric emergency room is crucial for ensuring both the physical and emotional well-being of young patients. Analgosedation, a combination of analgesia and sedation, is commonly used to facilitate various procedures in children. However, selecting the optimal agent and administration route remains challenging due to the unique pharmacological profiles and side effects of available drugs. This scoping review aims to provide a comprehensive analysis of the pharmacological agents used for procedural analgosedation in pediatric emergency settings, focusing on their efficacy, safety, administration routes, and potential side effects. A systematic review of the literature was conducted, focusing on key agents such as ketamine, midazolam, dexmedetomidine, fentanyl, and nitrous oxide. Studies were included based on their relevance to pediatric procedural sedation, particularly in emergency settings. Literature analysis showed that ketamine and fentanyl are effective for managing moderate to severe pain, with a rapid onset of action. Fentanyl is preferred for acute pain management following fractures and burns, while ketamine and midazolam are commonly used for emergency analgosedation. Dexmedetomidine, which induces sedation similar to natural sleep, is particularly effective in preventing pain and agitation during procedures and is well tolerated in children, especially those with developmental disorders. Nitrous oxide, when used in a 50% oxygen mixture, offers a valuable option for conscious sedation during mildly to moderately painful procedures, maintaining respiratory and airway reflexes. No single drug is ideal for all pediatric patients and procedures and the choice of agent should be tailored to the specific clinical scenario, considering both the sensory and affective components of pain. Future research should prioritize large-scale comparative studies, the exploration of combination therapies, and the development of non-pharmacological adjuncts to enhance the safety and efficacy of pediatric analgosedation.

pharmacology & pharmacy,chemistry, medicinal
Procedural anesthesia and sedation for children undergoing diagnostic and medical procedures - A review of postprocedural pain, nausea, and vomiting by questionnaire-based survey

Chloe Batchelor,Thomas Drake-Brockman,Andrew Lowe,Aine Sommerfield,Britta S von Ungern-Sternberg,David Sommerfield

DOI: https://doi.org/10.1111/pan.14334

Abstract:Background: Sedation and anesthesia are widely used to relieve pain and ensure cooperation during elective diagnostic and medical procedures in the pediatric population. However, there is currently limited evidence about the recovery trajectory following deep sedation or general anesthesia for such procedures in children. Aims: The primary aim was to describe the severity and duration of pain, nausea, and vomiting after common diagnostic and medical procedures. Secondary outcomes include return to baseline functioning and incidence of medical re-presentation. Methods: Recruitment was achieved postprocedurally by telephone interview with parents or legal guardians of patients who underwent botox injection, bronchoscopy, either or both a colonoscopy or upper gastrointestinal endoscopy, or MRI scan. Daily pain scores, nausea and vomiting, administration of at-home analgesia, and any adverse events requiring medical attention were obtained. Children were followed until pain completely resolved and baseline activity resumed. Results: A total of 307 patients were included (50 botox injection, bronchoscopy and MRI; 48 colonoscopy, 58 upper gastrointestinal endoscopy, 51 colonoscopy plus upper gastrointestinal endoscopy). Parental-rated pain scores peaked on day of procedure across all groups and decreased over time, with most children resuming normal activity within 1 day postprocedure. Pain was mostly mild and resolved quickly in botox injection (10% moderate to severe and 22% mild), bronchoscopy (8% and 10%, respectively), and MRI (2% mild) patients. Combined upper gastrointestinal endoscopy and colonoscopy was associated with greatest pain severity (29% moderate to severe and 20% mild). Highest rates of nausea and/or vomiting were observed in colonoscopy (23%), upper gastrointestinal endoscopy (28%), and combined procedure groups (20%). At-home simple analgesia was administered in 21% of patients. Unplanned medical re-presentations were infrequent across all groups. Conclusion: This study demonstrates that the recovery trajectory following procedural sedation and anesthesia is short, with minimal requirement for additional medical attention. These findings will aid in alleviating parental anxiety and encourage utilization of regular simple analgesia.
Historic Insights and Recent Innovations in Pediatric Regional Anesthesia

Ashley Mathew,Katrina Kerolus,Nicholas Bitonti,Andrea Guzman,Robert Moore,Sergio Bergese

DOI: https://doi.org/10.3390/jcm13226704

IF: 3.9

2024-11-09

Journal of Clinical Medicine

Abstract:Pediatric regional anesthesia is evolving with new peripheral nerve blocks and techniques aimed at improving perioperative pain management. While caudal blocks have long been standard due to their simplicity and low complication rates, newer fascial plane blocks offer comparable efficacy with enhanced nerve coverage tailored to specific surgeries. Moreover, adjuncts like dexmedetomidine and dexamethasone have shown promise in prolonging block duration and enhancing post-operative pain relief and patient satisfaction. The integration of these advancements into clinical practice has yielded significant benefits, including reduced intraoperative fluid requirements, decreased reliance on opioids postoperatively, earlier initiation of enteral nutrition, lower readmission rates, shorter hospital stays, and decreased overall hospital costs. Our review underscores the technical progress and expanding literature supporting the rapid adoption of these impactful regional anesthesia techniques in pediatric care.

medicine, general & internal
Chronic administration of octreotide ameliorates portal hypertension and portal hypertensive gastropathy in rats with cirrhosis.

C. Chan,F. Lee,S. S. Wang,F. Chang,H. Lin,H. J. Lin,C. Chu,S. L. Wu,C. Tai,S. D. Lee

DOI: https://doi.org/10.1042/CS0940367

1998-04-01

Clinical Science

Abstract:1. Portal hypertension and hyperdynamic circulation have been postulated to play a role in the pathogenesis of portal hypertensive gastropathy. Administration of octreotide to portal hypertensive rats has been shown to reduce portal pressure and ameliorate hyperdynamic circulation. 2. This study investigated the effects of chronic administration of octreotide on systemic and portal haemodynamics and the development of portal hypertensive gastropathy in carbon tetrachloride-induced cirrhotic rats. 3. After 12 weeks of carbon tetrachloride induction, cirrhotic rats were randomly assigned to receive either placebo (5% dextrose in water) or octreotide (65 micrograms/kg in 5% dextrose in water) subcutaneously twice daily for 10 days. Haemodynamic studies with a thermodilution technique and gastric morphometric analyses were performed at 10 days after treatment. 4. In cirrhotic rats, octreotide treatment induced a significant increase in systemic vascular resistance (2.7 +/- 0.2 versus 3.4 +/- 0.2 mmHg/ml.min-1.100 g-1, P < 0.05) and decrease in portal pressure (12.5 +/- 1.2 versus 9.9 +/- 0.5 mmHg, P < 0.05) compared with placebo-treated rats. In addition, octreotide treatment significantly reduced the mean cross-sectional area of gastric mucosal vessels (2290 +/- 145 versus 1810 +/- 101 micron 2, P < 0.05). 5. This study shows that chronic octreotide treatment ameliorates the development of portal hypertensive gastropathy in cirrhotic rats. The effect of octreotide on portal hypertensive gastropathy may, at least partly, be due to the alleviation of portal hypertension and hyperdynamic circulation.
Assessing modalities used to alleviate postoperative pain in children receiving dental treatment under general anaesthesia: a systematic review

Shivaranjhany Sivakumar,Annapurny Venkiteswaran,Muhammad Aidil Roslan,Sabri Musa

DOI: https://doi.org/10.22514/jocpd.2024.054

Abstract:Postoperative pain is generally a novel experience among paediatric patients. Topical anaesthetics, distraction procedures, and buffering of anaesthetic solutions have been used in reducing the postoperative pain. In this review, the authors assessed various modalities used to alleviate postoperative pain in children's dental treatment under general anaesthesia. Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) protocol were strictly adhered to in this systematic review. Specific keywords including postoperative pain, general anaesthesia, children, and dental extraction were used in the search for relevant randomized control trial studies in Web of Science, Scopus and PubMed, and included articles published until June 2021. From a total of 191 abstracts, 21 were reviewed. From the six studies with the usage of non-steroidal anti-inflammatory drugs (NSAIDs) alone or in combination with paracetamol, four observed that the preoperative use of NSAIDs alone or in combination was better than paracetamol alone, one discovered preoperative intravenous paracetamol was better than postoperative intravenous paracetamol, and the remaining study found no difference among various groups. Of two studies comparing the usage of non-steroidal anti-inflammatory drugs with opioid analgesics, one stated intravenous fentanyl in combination was better, while the other study found no difference among groups. The results obtained in this review can be utilized by physicians to control postoperative pain in children undergoing dental treatment under general anaesthesia.
The use of intranasal sufentanil and/or s‐ketamine for treatment of procedural pain in children in an ambulatory setting: A retrospective observational study

Bettina N. Nielsen,Steen W. Henneberg,Eva Malmros Olsson,Stefan Lundeberg

DOI: https://doi.org/10.1111/aas.14510

2024-08-20

Acta Anaesthesiologica Scandinavica

Abstract:Background Minor but painful medical procedures are often handled at the operating room. If safe and effective treatment options are available many procedures may be performed outside of the operating room. Objective(s) The objective of this study is to assess the adverse events of intranasal s‐ketamine and/or sufentanil alone or as part of a multimodal analgesic regime for medical procedures outside of the operating room. Secondary outcomes included analgesic effect, doses and indications for use. Design Retrospective observational study. Setting Tertiary care paediatric hospital. Patients Children 1 year up till 18 years. Intervention(s) Intranasal (IN) sufentanil (S), intranasal s‐ketamine (K) or the free combination of the two drugs (SK). Main Outcome Measure(s) The frequency of adverse events including serious adverse events reported by intervention. Results Between 2004 and 2014, 2185 medical procedures were registered, including 652 procedures with IN SK, 1469 procedures with IN S and 64 procedures with IN K. The children's median age was 5.6 years (range 1.0–17.9). Medical procedures with at least one adverse event were 18% with IN SK, 25% with IN K and 18% with IN S. Common adverse events included episodes of vomiting (9%), nausea (8%) and dizziness (3%). In two patients receiving IN S, serious adverse events occurred. One patient had respiratory depression and bronchospasm and another patient with cerebral palsy had a seizure. Both were handled immediately and did not result in any sequelae. The median doses of intranasal sufentanil were 38% lower when combined with s‐ketamine (IN SK free combination: sufentanil dose 0.5 μg/kg (range 0.2–1.3) and s‐ketamine dose 0.5 mg/kg (range 0.2–1.5). IN S monotherapy, sufentanil dose 0.8 μg/kg (range 0.2–2.7)). Similar analgesic effect was reported for S and SK. Conclusions Intranasal sufentanil and/or s‐ketamine are feasible for the treatment of procedural pain in an ambulatory setting with appropriate per‐ and post‐procedural observations and trained staff.

anesthesiology
Pediatric Analgesic Clinical Trial Designs, Measures, and Extrapolation: Report of an FDA Scientific Workshop

Charles B. Berde,Gary A. Walco,Elliot J. Krane,K. J. S. Anand,Jacob V. Aranda,Kenneth D. Craig,Carlton D. Dampier,Julia C. Finkel,Martin Grabois,Celeste Johnston,John Lantos,Alyssa Lebel,Lynne G. Maxwell,Patrick McGrath,Timothy F. Oberlander,Laura E. Schanberg,Bonnie Stevens,Anna Taddio,Carl L. von Baeyer,Myron Yaster,William T. Zempsky

DOI: https://doi.org/10.1542/peds.2010-3591

2012-02-01

PEDIATRICS

Abstract:Analgesic trials pose unique scientific, ethical, and practical challenges in pediatrics. Participants in a scientific workshop sponsored by the US Food and Drug Administration developed consensus on aspects of pediatric analgesic clinical trial design. The standard parallel-placebo analgesic trial design commonly used for adults has ethical and practical difficulties in pediatrics, due to the likelihood of subjects experiencing pain for extended periods of time. Immediate-rescue designs using opioid-sparing, rather than pain scores, as a primary outcome measure have been successfully used in pediatric analgesic efficacy trials. These designs maintain some of the scientific benefits of blinding, with some ethical and practical advantages over traditional designs. Preferred outcome measures were recommended for each age group. Acute pain trials are feasible for children undergoing surgery. Pharmacodynamic responses to opioids, local anesthetics, acetaminophen, and nonsteroidal antiinflammatory drugs appear substantially mature by age 2 years. There is currently no clear evidence for analgesic efficacy of acetaminophen or nonsteroidal antiinflammatory drugs in neonates or infants younger than 3 months of age. Small sample designs, including cross-over trials and N of 1 trials, for particular pediatric chronic pain conditions and for studies of pain and irritability in pediatric palliative care should be considered. Pediatric analgesic trials can be improved by using innovative study designs and outcome measures specific for children. Multicenter consortia will help to facilitate adequately powered pediatric analgesic trials.

pediatrics
Improving the Pediatric Procedural Experience: An Analysis of Pain, Anxiety, and Satisfaction

Caitlin E Crumm,Elizabeth A Camp,Maha Khalil,Corrie E Chumpitazi

DOI: https://doi.org/10.1177/2374373519836471

2019-11-26

Journal of Patient Experience

Abstract:Objective: The purpose of this investigation was to compare self-reported and perceived pain and anxiety among patients, caregivers, and providers before, during, and after common emergency department (ED) procedures while evaluating the impact of commonly used adjuncts on overall satisfaction. Methods: A prospective observational study of children undergoing painful procedures in an ED was conducted from January 2015 to March 2017. Before, during, and after the procedure, patients older than 3 years of age rated their pain and anxiety. At the same time points, the provider and caregiver rated their impression of the patient’s pain, and the caregiver also rated the patient’s anxiety. After the procedure, satisfaction was elicited from the caregiver and the provider. Results: A total of 257 children were enrolled: 150 for intravenous line placement, 53 for wound repair, and 44 for a variety of other procedures. Caregivers rated pain higher than providers before, during, and after the procedure ( P values <0.001, <0.001, and 0.003, respectively). Caregivers rated anxiety higher than patients before, during and after the procedure ( P values <0.001, 0.03, and 0.002, respectively). Providers were less satisfied with the 1- to 2-year age-group compared to the 8+ years age groups ( P values 0.01 and 0.002). Conclusions: Caregiver perception of pain and anxiety of the patient exceeds provider and sometimes patient reports. The youngest children present a challenge for caregivers and providers and have lower satisfaction compared to older groups.
PEACE-HYPNO – Management of procedural pain by multimodal sedation analgesia combining hypnosis in children with congenital heart disease: A randomized trial of non-inferiority

M. Gerard,E. Chambon

DOI: https://doi.org/10.1016/j.acvd.2024.07.022

IF: 3.196

2024-09-21

Archives of Cardiovascular Diseases

Abstract:Introduction Children with congenital heart disease often undergo painful procedures due to surgeries and associated care. While medications are commonly used for pain management during procedures like chest tube removal, they can have side effects. Non-pharmacological methods, such as therapeutic hypnosis, have shown effectiveness in reducing procedural pain and anxiety in children. However, there is limited research in this area, particularly in children, and none in children with congenital heart disease. Objective The objective of this study is to prove the non-inferiority of therapeutic hypnosis as a co-analgesic compared to standard analgesics during intrathoracic drain removal in children with congenital heart disease. Methods This study is a non-inferiority, randomized, controlled trial. Patients are randomized by computer. One group receive the conventional analgesia protocol including ketamine, midazolam, and MEOPA. The other group only receives MEOPA and lower doses of ketamine and undergo a hypnosis session by one of the service's professionals trained in medical hypnosis. Patient pain is self-assessed before and after the procedure. Patients are filmed throughout the drain removal so that per-procedure pain can be blindly evaluated from the randomization arm at a distance from the intervention. Finally, indirect signs of pain (HR, RR, SpO 2 ) are recorded before, during, and after the intervention. This study has been authorized by a French Committee of Ethics. Clinicaltrial.gov: NCT06373627 . Expected results Therapeutic hypnosis, when combined with minimal sedation-analgesia, is non-inferior to conventional sedation-analgesia in managing pain during chest tube removal in children with congenital heart disease. Perspectives This study would pave the way for wider adoption of therapeutic hypnosis as a co-analgesic method for children undergoing painful medical procedures, potentially reducing reliance on medications and enhancing patient experience.

cardiac & cardiovascular systems
Perioperative opioids in high-risk children undergoing tonsillectomy - A single institution experience

Asher C Park,Kathleen Billings,John Maddalozzo,Richard Dsida,Hubert A Benzon,Jennifer Lavin,Inbal Hazkani

DOI: https://doi.org/10.1016/j.amjoto.2024.104453

2024-08-08

Abstract:Background: Patients undergoing tonsillectomy/ adenotonsillectomy (T/AT) can experience substantial postoperative pain. The aims of this study are to assess perioperative pain management in high-risk children (children with severe obstructive sleep apnea and other complex medical comorbidities or age younger than 2 years) undergoing T/AT, and the impact on oxygen levels and pain during extended Post-Anesthesia Care Unit (PACU) admission. Methods: A retrospective case series study at a tertiary care children's hospital. Results: There were 278 children enrolled in the study. The Apnea-Hypopnea index and mean oxygen nadir on preoperative polysomnography were 31.3 ± 25.76/h and 79.5 ± 9.5 % respectively. Overall, 246 (89 %) patients received intraoperative opioids alone (n = 35, 13 %) or in combination with non-opioid analgesia (n = 209, 75 %). While the median dose of opioid-free medications (acetaminophen, ibuprofen) ranged from 93 to 100 % of standard maximal dosing by weight and age, the median dose of opioids was significantly lower and ranged from 54 to 63 % of standard maximal dosing by weight and age, with 43 % of the patients receiving less than half the recommended maximum dose. Oxygen desaturation was charted in 21 patients (8 %) during their PACU admission. Patients who received opioid-free analgesia were as likely to develop oxygen desaturations (n = 17 (81 %) vs. n = 228 (89.4 %), p = 0.27) and to receive rescue pain medication during their PACU stay as patients who received opioids intraoperatively (n = 18 (56 %) vs. n = 167 (68 %), p = 0.23). Conclusions: Intraoperative pain management varies across high-risk pediatric tonsillectomies. Opioid-free analgesia was not associated with an increased need for pain medications during PACU admission, or with a decreased likelihood of oxygen desaturations compared to intra-operative opioid analgesia use.
The Use of Multimodal Perineural Adjuvants in Pediatric Peripheral Nerve Blocks: Technique and Experiences

Sampaguita P. Tafoya,Sundeep S. Tumber,SUNDEEP S. TUMBER,Sampaguita P Tafoya,Sundeep S Tumber

DOI: https://doi.org/10.7759/cureus.23186

2022-03-15

Cureus

Abstract:Background Postoperative pain management in pediatric population can be very challenging. How to prolong the duration of single-injection peripheral nerve blocks has been widely discussed. Multiple medications are under investigation to accomplish this, yet data specifically focused on their use in pediatric peripheral nerve blocks are limited. Methods Anesthetic electronic medical records were queried for any instances where adjuvant drug(s) were used in peripheral nerve blocks during a two-year period at a pediatric surgical specialty hospital. These included buprenorphine, clonidine, dexamethasone, and dexmedetomidine. Results Out of 1,845 blocks placed during the study period, 1,148 (62.2%) utilized perineural adjuvants. Buprenorphine as a sole agent was the most common choice (49.5%), followed by buprenorphine and dexmedetomidine combined (39.9%), dexmedetomidine alone (10.1%), and the rare combination of all three drugs, buprenorphine, dexmedetomidine, and dexamethasone (0.5%). The mean dose of buprenorphine given was 3.6 mcg/kg total, 2.8 mcg/kg/block. The mean dose of dexmedetomidine given was 0.9 mcg/kg total, 0.6 mcg/kg/block. The mean dose of dexamethasone utilized was 2 mg total, 1 mg/block. Conclusions This report examined one institution's use of multimodal perineural adjuvants in over 1,000 pediatric peripheral nerve blocks. Buprenorphine was the agent most commonly used to prolong the single-injection peripheral nerve block. This highlights the need for future prospective trials evaluating efficacy and safety.
[Health care alarmists counteracts quality development].

J. Nordenström

2017-01-12

Abstract:
Exploring Non-Pharmacological Management among Anesthesia Providers to Reduce Preoperative Distress in Children

Rossana Bizzio,Rosina Cianelli,Natalia Villegas,Mary Hooshmand,Melisia Robinson,Kimberly A Hires,Alexandra Stathas

DOI: https://doi.org/10.1016/j.pedn.2019.11.005

Abstract:Preparation for surgery with the induction of general anesthesia is one of the most stressful events that a child can experience. It produces several threats to the child, including physical harm, parent separation, and fear of the unknown. Anesthesia providers utilize non-pharmacological and pharmacological interventions to decrease this preoperatively. However, little is known about the non-pharmacological interventions utilized by anesthesia providers in practice. The purpose of this study was to explore non-pharmacological interventions utilized by anesthesia providers before and during the induction of general anesthesia to reduce preoperative distress in children ages one to six years old. A qualitative descriptive approach was used in this study. Twenty anesthesia providers, fourteen registered nurse anesthetists and six anesthesiologists, participated in face to face, in-depth interviews in South Florida. Content analysis was used to identify and define the major themes that emerged from the interviews. A total of seven main themes were identified. Only the three themes directly related to parent-provider-child relationship are discussed in this paper: (I) Communication, (II) Observational Skills, and (III) Parental Presence. The anesthesia providers who participated in this study offered an opportunity to better understand the non-pharmacological interventions used to impact the management of preoperative distress among children. Study findings provide evidence about non-pharmacological anesthesia providers' clinical work not found elsewhere in the literature. Non-pharmacological interventions are effective in reducing preoperative distress in children.
Auxiliary Aids to Alleviate Pain and Anxiety during Local Anesthesia Administration: A Comparative Study

Vishu Midha,Vasu Midha,Rohini Dua,Ripin Garewal,Anuraj S Kochhar,Gulsheen K Kochhar

DOI: https://doi.org/10.5005/jp-journals-10005-1935

2021-01-01

International Journal of Clinical Pediatric Dentistry

Abstract:INTRODUCTION: In dentistry, pain and anxiety have been the most challenging aspect in the management of a pediatric patient. When every effort to perform local anesthesia (LA) is not successful, the result would be more stressful for both the dentist and the patient. The so-called clichéd paradigm that "pain and dentistry are inseparable" can be resolved by updating the knowledge and skills of the practitioner by using the more advanced techniques in controlling and managing the pain. An array of techniques for administering the LA to improve the comfort level of our patients has been the area of interest.AIM AND OBJECTIVE: To evaluate and compare the efficacy of various adjunctive aids of LA in reducing pain and anxiety in pediatric patients of the 6-8 years age-group. A total of 90 child dental patients were selected and randomly divided into six groups, i.e., control, topical gel, audio, audiovisual, transcutaneous electric nerve stimulation (TENS), and Vibraject group. Physiological parameters, psychological parameters, and pain assessment were recorded.RESULTS: As reflected by the results, the minimum pulse rate "during" and "after" LA administration is seen in A/V (D) and TENS (E) "during" LA administration. Children were less anxious and more relaxed in the audiovisual group and TENS group. Transcutaneous electric nerve stimulation and Vibraject groups showed maximum reduction in pain.CONCLUSION: A/V (D) and TENS (E) groups exhibited the least anxiety. Also, the minimum pain was felt using TENS (E) and Vibraject (F) and hence, may be considered as adjunctive aids in pain reduction during LA administration.HOW TO CITE THIS ARTICLE: Midha V, Midha V, Dua R, <i>et al.</i> Auxiliary Aids to Alleviate Pain and Anxiety during Local Anesthesia Administration: A Comparative Study. Int J Clin Pediatr Dent 2021;14(1):104-108.
Optimal Sedation and Pain Management: A Patient- and Symptom-Oriented Paradigm

Yahya Shehabi,Wisam Al-Bassam,Adrian Pakavakis,Brendan Murfin,Belinda Howe

DOI: https://doi.org/10.1055/s-0040-1716736

2020-09-21

Seminars in Respiratory and Critical Care Medicine

Abstract:Abstract In the critically ill patient, optimal pain and sedation management remains the cornerstone of achieving comfort, safety, and to facilitate complex life support interventions. Pain relief, using multimodal analgesia, is an integral component of any orchestrated approach to achieve clinically appropriate goals in critically ill patients. Sedative management, however, remains a significant challenge. Subsequent studies including most recent randomized trials have failed to provide strong evidence in favor of a sedative agent, a mode of sedation or ancillary protocols such as sedative interruption and sedative minimization. In addition, clinical practice guidelines, despite a comprehensive evaluation of relevant literature, have limitations when applied to individual patients. These limitations have been most apparent during the coronavirus disease 2019 pandemic. As such, there is a need for a mindset shift to a practical and achievable sedation strategy, driven by patients' characteristics and individual patient needs, rather than one cocktail for all patients. In this review, we present key principles to achieve patient-and symptom-oriented optimal analgesia and sedation in the critically ill patients. Sedative intensity should be proportionate to care complexity with due consideration to an individual patient's modifiers. The use of multimodal analgesics, sedatives, and antipsychotics agents—that are easily titratable—reduces the overall quantum of sedatives and opioids, and reduces the risk of adverse events while maximizing clinical benefits. In addition, critical considerations regarding the choice of sedative agents should be given to factors such as age, medical versus operative diagnosis, and cardiovascular status. Specific populations such as trauma, neurological injury, and pregnancy should also be taken into account to maximize efficacy and reduce adverse events.

respiratory system,critical care medicine
Deformation mechanisms in nanotwinned metal nanopillars.

D. Jang,Xiaoyan Li,Huajian Gao,J. Greer

DOI: https://doi.org/10.1038/nnano.2012.116

IF: 38.3

2012-09-01

Nature Nanotechnology

Abstract:

Optimizing pediatric periprocedural pain management part I—Evolving ethics and topical anesthetics

A Narrative Review of Pain in Pediatric Oncology: The Opioid Option for Procedural and Surgical Pain

Updates from the Other Side of the Drape: Recent Advances in Multimodal Pain Management and Opioid Reduction Among Pediatric Surgical Patients

Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults.

Analgosedation in Pediatric Emergency Care: A Comprehensive Scoping Review

Procedural anesthesia and sedation for children undergoing diagnostic and medical procedures - A review of postprocedural pain, nausea, and vomiting by questionnaire-based survey

Historic Insights and Recent Innovations in Pediatric Regional Anesthesia

Chronic administration of octreotide ameliorates portal hypertension and portal hypertensive gastropathy in rats with cirrhosis.

Assessing modalities used to alleviate postoperative pain in children receiving dental treatment under general anaesthesia: a systematic review

The use of intranasal sufentanil and/or s‐ketamine for treatment of procedural pain in children in an ambulatory setting: A retrospective observational study

Pediatric Analgesic Clinical Trial Designs, Measures, and Extrapolation: Report of an FDA Scientific Workshop

Improving the Pediatric Procedural Experience: An Analysis of Pain, Anxiety, and Satisfaction

PEACE-HYPNO – Management of procedural pain by multimodal sedation analgesia combining hypnosis in children with congenital heart disease: A randomized trial of non-inferiority

Perioperative opioids in high-risk children undergoing tonsillectomy - A single institution experience

The Use of Multimodal Perineural Adjuvants in Pediatric Peripheral Nerve Blocks: Technique and Experiences

[Health care alarmists counteracts quality development].

Exploring Non-Pharmacological Management among Anesthesia Providers to Reduce Preoperative Distress in Children

Auxiliary Aids to Alleviate Pain and Anxiety during Local Anesthesia Administration: A Comparative Study

Optimal Sedation and Pain Management: A Patient- and Symptom-Oriented Paradigm

Deformation mechanisms in nanotwinned metal nanopillars.